Sam Williams, PhD Joins CATALYSIS as Senior Advisor

CATALYSIS CAPITAL PARTNERS is pleased to announce that Sam Williams, PhD has joined CATALYSIS as a Senior Advisor. Sam Williams has over 10 years’ experience in investment banking focusing on biotechnology and pharmaceuticals, most recently at Lehman Brothers where he held the position of Industry Group Leader for European Pharmaceuticals and Chemicals. Sam Williams was ranked the number one European Biotechnology equity analyst by Institutional Investor magazine in 2004, 2005 and 2006 and by Thomson Extel in 2004 and 2005. Read more